FILTER

FILTERED INTERVIEW RESULTS

Chris Garabedian

CHAIRMAN AND CEO, XONTOGENY
"People are realizing that our sector may need to be more discerning in deciding which companies are worthy and mature enough to bring to the public markets."

Michael Quirmbach

CEO & PRESIDENT, CORDENPHARMA
"Through our growing network of cGMP facilities across Europe and the US, we aim to continue to translate complex processes and projects at any stage of development into high-value products."

Satya Vadlamani

CHAIRPERSON & MANAGING DIRECTOR, MURLI KRISHNA PHARMA PVT LTD
"We established a dynamic drug delivery systems (DDS) company focused on providing a range of effective solutions to optimize the delivery of pharmaceutical products."

Gil Roth

PRESIDENT, PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION (PBOA)
"The pandemic highlighted the key role that CDMOs play, and we need a voice to drive consensus internally, face regulators, and ensure we have a seat at the table."

Michael Zahra

FORMER PRESIDENT & CEO, DRONE DELIVERY CANADA
"Remote projects may prefer to isolate and limit the number of external individuals visiting as a precaution to avoid the virus spreading, but they need to maintain their supply chain so drones are a perfect unmanned logistics solution."

Marco Mastrodonato

FOUNDER AND CEO, BMG PHARMA
BMG explains the potential of its modified hyaluronic acid technology.

Omar Alessandrini

CEO, Biomedical Pharma
Biomedical Pharma explains the huge scope for its photocatalytic cleaning products.

Stefano Collatina

COUNTRY LEAD, BAXTER
Baxter in Italy outlines its operations and outlook.

Vittorio Broccoli & Maud Saillard

EXPORT SALES EXECUTIVES, ERBOZETA
Erbozeta explains how it maintains a high level of growth.

Massimo Montironi

CEO, IDI FARMACEUTICI
IDI Farmaceutici develops and produces products for the cure and treatment of skin conditions.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Latin America Petrochemicals and Chemicals 2024 - Digital Interactive

The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.

PARTNER EVENTS